Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Brain Neoplasms 4Neoplasms 3Prostatic Neoplasms 2Urogenital Neoplasms 1Radiation Pneumonitis 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Optic Neuritis 1Neoplasm Metastasis 1Myelitis, Transverse 1Myelitis 1Myasthenia Gravis 1Lung Neoplasms 1Lung Diseases, Interstitial 1Hematologic Neoplasms 1Graft vs Host Disease 1Glioma 1Genital Neoplasms, Male 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 88Carboplatin 77Specimen Handling 76Magnetic Resonance Spectroscopy 63Pemetrexed 59Cisplatin 47durvalumab 44Paclitaxel 38Nivolumab 34atezolizumab 32osimertinib 29Radiotherapy 29Radiosurgery 29Biopsy 26Blood Specimen Collection 25Gemcitabine 24Docetaxel 24Immunoglobulin G 23Disulfides 22Standard of Care 21Drug Therapy 21Etoposide 19Taxes 18Practice Guidelines as Topic 18Radiation 17Educational Status 16130-nm albumin-bound paclitaxel 15X-Rays 14Surveys and Questionnaires 14Bevacizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Adrenal Cortex Hormones × 1 year × Clear all
NCT05986318 2026-03-09

RESPIRE-ILD

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Recruiting
98 enrolled
Thoracic

Lung Neoplasms, Lung Diseases, Interstitial, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡